Ozempic (semaglutide) injection for Type 2 Diabetes
Key facts
- country: United States
- sector: Health Care
Classified as: organization
News:
- Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
- Wegovy and Ozempic top list of 15 drugs up for next price negotiations
- Ozempic, Wegovy top list of Biden's price-negotiation drugs
- Ozempic picked for Medicare price bargaining
Summary
Ozempic (semaglutide) injection for Type 2 Diabetes is a company. It is located in the United States. The company is part of the Health Care sector.
Business
Ozempic (semaglutide) injection for Type 2 Diabetes is one of the companies in the United States, companies in Health Care and 3,466,499 companies in our database.
Stocks from Ozempic (semaglutide) injection for Type 2 Diabetes
Explore more on business
Talking Points:
- Ozempic® (semaglutide) injection for Type 2 Diabetes
- Ozempic® (semaglutide) injection is a once-weekly GLP-1 RA medicine that, along with diet and exercise, may help improve blood sugar in adults with type 2 diabetes. Read Important Safety Information, including Boxed Warning.
Learn more about talking points